BROADCASTS.com

Anti-parsitic pharmaceuticals such as Ivermectin and Hydroxychloroquine have shown some promise in medical trials for COVID 19, especially when taken early after the onset of symptoms, and in moderate doses. There has been some arguments about these studies. For example, one of the most prestigious medical journals, the Lancet, published a paper that claimed to show that Hydroxychloroquine was not safe or effective. It was shortly after this study was published that the WHO and CDC stopped their clinical trials for Hydroxychloroquine. However the Lancet later retracted that study, and apologized to their readers, saying that they could not confirm the data provided in the study! This was only after an open letter, signed by nearly 150 prominent doctors was sent to the Lancet, that pointed out the clear inconsistencies with the study.